Drug Search Results
More Filters [+]

MLN-4760

Alternative Names: mln-4760, mln 4760, mln4760, ore-1001, ore 1001, ore1001
Latest Update: 2024-02-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: ACE Inhibitor

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Ore
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for MLN-4760

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Colitis, Ulcerative

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

ORX102

P2

Unknown status

Colitis, Ulcerative

2011-06-01

Recent News Events